UBS Group’s Danimer Scientific, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class DNMR.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,596
Closed -$41K 10312
2021
Q1
$41K Buy
+1,596
New +$40.1K ﹤0.01% 6758

UBS Group's DNMR.WS Position: Q2 2021 in Review

UBS Group sold out of Danimer Scientific, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class (DNMR.WS) in Q2 2021, closing a stake of 1,596 shares — an estimated $41K sold.

UBS Group first reported a position in DNMR.WS in Q1 2021 and held it in 1 quarter. The position peaked at $41K in Q1 2021. 0 funds tracked by Wall St. Rank hold DNMR.WS as of Q2 2021.

  • UBS Group reported no remaining Danimer Scientific, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class position as of Q2 2021 after selling out during the quarter.
  • UBS Group sold 1,596 Danimer Scientific, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class shares in Q2 2021, an estimated $41K.
  • UBS Group first reported a position in Danimer Scientific, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class in Q1 2021 and held it in 1 quarter.
  • UBS Group's Danimer Scientific, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class position peaked at $41K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Danimer Scientific, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class as of Q2 2021.

Based on UBS Group's 13F filing for Q2 2021, filed 13 Aug 2021.